About Us

Your link to us

At Solulink, we develop high-performance products that link biomolecules together. Our continuous efforts in new product development and service offerings enable you to remain at the forefront of advanced bioscience research.

Our products are developed with you in mind. As we refine our products and develop new ones, we continue to link up with researchers to help guide our development. Milestones such as the NanoLink™ or MagnaLink™ Streptavidin Magnetic Beads with the highest available binding capacity, ChromaLink™ Antibody Labeling Kit and the antibody-oligo conjugation versions of our kits represent our commitment to consistently providing innovative products to meet the changing needs of our customers.

We are continually adding more user-friendly features to our linker capability and kits. We are now the first company offering complete antibody labeling kits with purification included. And we are developing more exciting new conjugation kits, all based on the same successful product ideals: Versatile products that are easy to use, quantitative and affordable.

Conjugation: At the Heart of Biotechnology Methods

Bioconjugation technologies, enabling the linking of biomolecules to reporters, surfaces, or other biomolecules, constitute a key tool kit enabling many classes of reagents which power modern biotechnologies such as flow cytometry, immunohistochemistry (“IHC”), Enzyme-Linked Immunosorbent Assay (“ELISA”), Western blotting, next generation sequencing, gene expression microarrays, bead-based cell isolation and multiplexed assays, and bioactive surfaces. But even as biotechnology’s need for higher-performance conjugation chemistries grows ever greater, bio-linking technologies have largely stagnated following the introductions of the unstable and unreliable streptavidin/biotin and maleimide chemistries for protein conjugation in the 1960s.

Solulink’s Established and Growing Business

Established in 2003, Solulink, Inc. (“Solulink” or the “Company”) is a rising new player in the delivery of high-performance bioconjugation chemistries addressing the biotechnology industry’s longstanding need for conjugation chemistry with milder reaction conditions, higher efficiencies, and greater stability and technical simplicity. The Company’s proprietary HyNic/4FB chemistry is unique among bioconjugation methods in combining superb stability with high specificity and versatility, suitable for conjugation of all classes of biomolecules, including peptides, proteins, oligonucleotides, and carbohydrates, with all types of labels, including fluorophores, chromogenic moieties, surfaces, and small molecules. HyNic/4FB chemistry underlies the majority of Solulink’s extensive product catalog, comprised of various kits and tools that enable efficient and stable antibody, bead, and oligonucleotide labeling. The Company maintains a growing customer base which today exceeds 1,400 active accounts, including OEM and supply agreements with leading biotechnology companies, pharmaceutical companies and prestigious research institutes worldwide.

To learn more about Solulink's technology, click here.

Terms of Use
Products and materials supplied by Solulink are for the purchaser's internal research use only. Internal research use only for scientific investigation performed at the purchaser's organization. Solulink material may not be used for any diagnostic, therapeutic or commercial use without a license from Solulink. Commercial purpose means any use for which you are compensated including any use in the manufacture of a product, information or data sale or any resale, repackaging or other transfer for consideration. Commercial licenses are available, please inquire.

Solulink's Latest Headlines

6/2015 - Solulink and TriLink BioTechnologies Enter into Manufacturing and Distribution Agreement

1/24/14 - An article discussing Solulink’s new revolutionary dye mix and match antibody labeling technology, HybriLink™ was published in the January 24, 2014, ChemBioChem Journal. The article is the result of a collaboration between the University of Chicago and Solulink:
DNA-Directed Assembly of Antibody–Fluorophore Conjugates for Quantitative Multiparametric Flow Cytometry

Solulink Appoints Life Science Industry Veteran Jack Ball as Chief Executive Officer